Study Ties Pfizer Anti-Smoking Drug To Heart Problems
Pfizer Inc.'s smoking cessation drug Chantix has been linked to serious cardiovascular problems, such as congestive heart failure and stroke, according to an analysis published by a Canadian medical journal on...To view the full article, register now.
Already a subscriber? Click here to view full article